KATHLEEN SMITH: Open Payments
NPI 1841392883 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 12 payments from 10 companies in 2025. Trend: 2023 $391 · 2024 $589 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $2 |
Products named: JARDIANCE, FANAPT, ELIQUIS, Saxenda, Jornay PM, TRELEGY ELLIPTA, MOUNJARO, NUZYRA.
Industry payments across IN — which companies pay providers there.
